避孕药首诊登记和随访情况的帕累托图分析  

Pareto Diagram Analysis on Initial Registration and Follow-up of Contraceptives

作　　者：陈颖[1] 朱向珺[1] 周健[1] 巴磊[1] 姚捷[1] 孙志明[1] 李瑛[1] 

机构地区：[1]国家人口计生委计划生育药具不良反应监测中心暨江苏省计划生育科学技术研究所,江苏南京210036

出　　处：《中国药物警戒》2015年第2期114-116,119,共4页Chinese Journal of Pharmacovigilance

基　　金："十一五国家科技支撑计划课题"避孕药具上市后监测和风险再评价研究(2006BAI15B07);中央财政专项"避孕药具不良反应监测与防治";江苏省科技厅项目"避孕药具监测数据挖掘与风险评价模型研究特色业务建设"(BM2012062)

摘　　要：目的分析避孕药使用前的健康筛查和使用后的随访情况。方法对避孕药使用前健康筛查和随访中存在的问题进行分类,用帕累托图法进行分析。结果帕累托图法分析的避孕药使用前健康筛查和随访中存在的主要问题是健康筛查和随访时检查项目不全面,其他问题是特殊对象未加强随访、用药不符合说明书要求和1次发药量过多。高危对象在用药前筛查时均未做宫颈细胞学检查,20%未加强随访,83.33%在随访中检查项目不全面。结论应落实避孕药品首诊登记制度和随访服务规范,提高使用避孕药的安全性和有效性。Objective To analyze the situation of the first-diagnosed registration and follow-up for contraceptives. Methods The Pareto diagram analysis was used to make the classification of the problems in the first-diagnosed registration and follow-up for contraceptives. Results The examinations are incomplete in initial registration and follow-up, which is the primary problem. The other problems are that special women do not have intensive follow-up services, medication does not meet the specification requirements and women are dispensed too many contraceptives once. Neither of high-risk women do cervical cytology screening before treatment, 20%of which have no intensive follow-up. 83.33%of the follow-up don＆#39;t have complete examinations. Conclusion The first-diagnosed initial registration and follow-up system should be implemented, in order to improve the safety and effectiveness of contraceptives.

关 键 词：避孕药 首诊登记 随访 帕累托图 

分 类 号：R95[医药卫生—药学]